Novel Routes of Potential Hepatitis C Virus Transmission among People Who Inject Drugs: Secondary Blood Exposures Related to Injection Drug Use

References

• Afdhal, N., McHutchison, J., Brown, R., Jacobson, I., Manns, M., Poordad, F., Weksler, B., & Esteban, R. (2008). Thrombocytopenia associated with chronic liver disease. Journal of Hepatology, 48(6), 1000–1007. https://doi.org/10.1016/j.jhep.2008.03.009
   PubMed Web of Science ®Google Scholar
• Akbarzadeh, V., Mumtaz, G. R., Awad, S. F., Weiss, H. A., & Abu-Raddad, L. J. (2016). HCV prevalence can predict HIV epidemic potential among people who inject drugs: Mathematical modeling analysis. BMC Public Health, 16(1), 1216. https://doi.org/10.1186/s12889-016-3887-y
   PubMedGoogle Scholar
• Aspinall, E. J., Weir, A., Sacks-Davis, R., Spelman, T., Grebely, J., Higgs, P., Hutchinson, S. J., & Hellard, M. E. (2014). Does informing people who inject drugs of their hepatitis C status influence their injecting behaviour? Analysis of the Networks II study. The International Journal on Drug Policy, 25(1), 179–182. https://doi.org/10.1016/j.drugpo.2013.08.005
   PubMed Web of Science ®Google Scholar
• Bluthenthal, R. N., Heinzerling, K. G., Anderson, R., Flynn, N. M., & Kral, A. H. (2008). Approval of Syringe Exchange Programs in California: Results From a Local Approach to HIV Prevention. American Journal of Public Health, 98(2), 278–283. https://doi.org/10.2105/AJPH.2005.080770
   PubMed Web of Science ®Google Scholar
• Bruneau, J., Zang, G., Abrahamowicz, M., Jutras-Aswad, D., Daniel, M., & Roy, É. (2014). Sustained Drug Use Changes After Hepatitis C Screening and Counseling Among Recently Infected Persons Who Inject Drugs: A Longitudinal Study. Clinical Infectious Diseases, 58(6), 755–761. https://doi.org/10.1093/cid/cit938
   PubMed Web of Science ®Google Scholar
• Carey, J., Perlman, D. C., Friedmann, P., Kaplan, W. M., Nugent, A., Deutscher, M., Masson, C. L., & Des Jarlais, D. C. (2005). Knowledge of hepatitis among active drug injectors at a syringe exchange program. J Subst Abuse Treat, 29(1), 47–53. https://doi.org/10.1016/j.jsat.2005.03.004
   PubMed Web of Science ®Google Scholar
• Cook, C., Bridge, J., McLean, S., Phelan, M., Barrett, D. (2014). The funding crisis for harm reduction: Donor retreat, government neglect and the way forward. https://www.hri.global/files/2014/09/22/Funding_report_2014.pdf
   Google Scholar
• Cooper, H. L. F., Brady, J. E., Ciccarone, D., Tempalski, B., Gostnell, K., & Friedman, S. R. (2007). Nationwide Increase in the Number of Hospitalizations for Illicit Injection Drug Use-Related Infective Endocarditis. Clinical Infectious Diseases, 45(9), 1200–1203. https://doi.org/10.1086/522176
   PubMed Web of Science ®Google Scholar
• Cooper, H. L. F., Linton, S., Kelley, M. E., Ross, Z., Wolfe, M. E., Chen, Y.-T., Zlotorzynska, M., Hunter-Jones, J., Friedman, S. R., Des Jarlais, D., Semaan, S., Tempalski, B., DiNenno, E., Broz, D., Wejnert, C., & Paz-Bailey, G., National HIV Behavioral Surveillance Study Group. (2016). Racialized risk environments in a large sample of people who inject drugs in the United States. The International Journal on Drug Policy, 27, 43–55. https://doi.org/10.1016/j.drugpo.2015.07.015
   PubMed Web of Science ®Google Scholar
• De, P., Roy, É., Boivin, J.-F., Cox, J., & Morissette, C. (2008). Risk of hepatitis C virus transmission through drug preparation equipment: A systematic and methodological review. Journal of Viral Hepatitis, 15(4), 279–292. https://doi.org/10.1111/j.1365-2893.2007.00942.x
   PubMed Web of Science ®Google Scholar
• Deren, S., Beardsley, M., Tortu, S., & Goldstein, M. F. (1998). HIV Serostatus and changes in risk behaviors among drug injectors and crack users. AIDS and Behavior, 2(2), 171–176. https://doi.org/10.1023/A:1022103131608
   Google Scholar
• Deutscher, M., & Perlman, D. C. (2008). Why some injection drug users lick their needles: A preliminary survey. The International Journal on Drug Policy, 19(4), 342–345. https://doi.org/10.1016/j.drugpo.2007.06.006
   PubMed Web of Science ®Google Scholar
• Disease Burden from Viral Hepatitis A, B, and C in the United States | CDC. (2019, January 3). Retrieved February 10, 2019, from https://www.cdc.gov/hepatitis/statistics/DiseaseBurden.htm
   Google Scholar
• Doerrbecker, J., Friesland, M., Ciesek, S., Erichsen, T. J., Mateu-Gelabert, P., Steinmann, J., Steinmann, J., Pietschmann, T., & Steinmann, E. (2011). Inactivation and Survival of Hepatitis C Virus on Inanimate Surfaces. The Journal of Infectious Diseases, 204(12), 1830–1838. https://doi.org/10.1093/infdis/jir535
   PubMed Web of Science ®Google Scholar
• Dowling-Guyer, S., Johnson, M. E., Fisher, D. G., Needle, R., Watters, J., Andersen, M., Williams, M., Kotranski, L., Booth, R., Rhodes, F., Weatherby, N., Estrada, A. L., Fleming, D., Deren, S., & Tortu, S. (1994). Reliability of drug users’ self-reported HIV risk behaviors and validity of self-reported recent drug use. Assessment, 1(4), 383–392. https://doi.org/10.1177/107319119400100407
   Google Scholar
• Fisher, J. D., Misovich, S. J., Kimble, D. L., & Weinstein, B. (1999). Dynamics of HIV risk behavior in HIV-infected injection drug users. AIDS and Behavior, 3(1), 41–57. https://doi.org/10.1023/A:1025467402830
   Google Scholar
• Fleischauer, A. T., Ruhl, L., Rhea, S., & Barnes, E. (2017). Hospitalizations for Endocarditis and Associated Health Care Costs Among Persons with Diagnosed Drug Dependence—North Carolina, 2010–2015. MMWR. Morbidity and Mortality Weekly Report, 66(22), 569–573. https://doi.org/10.15585/mmwr.mm6622a1
   PubMed Web of Science ®Google Scholar
• Garten, R. J., Lai, S., Zhang, J., Liu, W., Chen, J., Vlahov, D., & Yu, X.-F. (2004). Rapid transmission of hepatitis C virus among young injecting heroin users in Southern China. International Journal of Epidemiology, 33(1), 182–188. https://doi.org/10.1093/ije/dyh019
   PubMed Web of Science ®Google Scholar
• Gray, M. E., Rogawski McQuade, E. T., Scheld, W. M., & Dillingham, R. A. (2018). Rising rates of injection drug use associated infective endocarditis in Virginia with missed opportunities for addiction treatment referral: A retrospective cohort study. BMC Infectious Diseases, 18(1), 532. https://doi.org/10.1186/s12879-018-3408-y
   PubMedGoogle Scholar
• Green, T. C., Martin, E. G., Bowman, S. E., Mann, M. R., & Beletsky, L. (2012). Life After the Ban: An Assessment of US Syringe Exchange Programs’ Attitudes About and Early Experiences With Federal Funding. American Journal of Public Health, 102(5), e9–e16. https://doi.org/10.2105/AJPH.2011.300595
   PubMedGoogle Scholar
• Hagan, H., Campbell, J., Thiede, H., Strathdee, S., Ouellet, L., Kapadia, F., Hudson, S., & Garfein, R. S. (2006). Self-reported Hepatitis C virus antibody status and risk behavior in young injectors. Public Health Reports (Washington, D.C. : 1974)), 121(6), 710–719. https://doi.org/10.1177/003335490612100611
   PubMed Web of Science ®Google Scholar
• Hagan, H., Des Jarlais, D. C., Stern, R., Lelutiu-Weinberger, C., Scheinmann, R., Strauss, S., & Flom, P. L. (2007). HCV Synthesis Project: Preliminary analyses of HCV prevalence in relation to age and duration of injection. International Journal of Drug Policy, 18(5), 341–351. https://doi.org/10.1016/j.drugpo.2007.01.016
   PubMed Web of Science ®Google Scholar
• Hagan, H., Pouget, E. R., Des Jarlais, D. C., & Lelutiu-Weinberger, C. (2008). Meta-Regression of Hepatitis C Virus Infection in Relation to Time Since Onset of Illicit Drug Injection: The Influence of Time and Place. American Journal of Epidemiology, 168(10), 1099–1109. https://doi.org/10.1093/aje/kwn237
   PubMed Web of Science ®Google Scholar
• Hagan, H., Pouget, E. R., Williams, I. T., Garfein, R. L., Strathdee, S. A., Hudson, S. M., Latka, M. H., & Ouellet, L. J. (2010). Attribution of Hepatitis C Virus Seroconversion Risk in Young Injection Drug Users in 5 US Cities. The Journal of Infectious Diseases, 201(3), 378–385. https://doi.org/10.1086/649783
   PubMed Web of Science ®Google Scholar
• Hagan, H., Thiede, H., Weiss, N. S., Hopkins, S. G., Duchin, J. S., & Alexander, E. R. (2001). Sharing of drug preparation equipment as a risk factor for hepatitis C. American Journal of Public Health, 91(1), 42–46. https://doi.org/10.2105/ajph.91.1.42
   PubMed Web of Science ®Google Scholar
• Heimer, R., Binka, M., Koester, S., Grund, J.-P. C., Patel, A., Paintsil, E., & Lindenbach, B. D. (2018). Recovery of Infectious Hepatitis C Virus From Injection Paraphernalia: Implications for Prevention Programs Serving People Who Inject Drugs. The Journal of Infectious Diseases, 217(3), 466–473. HYPERLINK “https://doi.org/10.1093/infdis/jix427” https://doi.org/10.1093/infdis/jix
   PubMed Web of Science ®Google Scholar
• Heimer, R., Clair, S., Grau, L. E., Bluthenthal, R. N., Marshall, P. A., & Singer, M. (2002). Hepatitis-associated knowledge is low and risks are high among HIV-aware injection drug users in three US cities. Addiction (Abingdon, England)), 97(10), 1277–1287. https://doi.org/10.1046/j.1360-0443.2002.t01-1-00211.x
   PubMed Web of Science ®Google Scholar
• Hofmeister, M. G., Rosenthal, E. M., Barker, L. K., Rosenberg, E. S., Barranco, M. A., Hall, E. W., Edlin, B. R., Mermin, J., Ward, J. W., & Ryerson, A. B. (2019). Estimating prevalence of hepatitis C virus infection in the United States, 2013–2016. Hepatology (Baltimore, Md.), 69(3), 1020–1031. https://doi.org/10.1002/hep.30297
   PubMed Web of Science ®Google Scholar
• Keeshin, S. W., & Feinberg, J. (2016). Endocarditis as a Marker for New Epidemics of Injection Drug Use. The American Journal of the Medical Sciences, 352(6), 609–614. https://doi.org/10.1016/j.amjms.2016.10.002
   PubMed Web of Science ®Google Scholar
• Koester, S. (1994). Copping, Running, and Paraphernalia Laws: Contextual Variables and Needle Risk Behavior among Injection Drug Users in Denver. Human Organization, 53(3), 287–295. https://doi.org/10.17730/humo.53.3.g86872408528021h
   Web of Science ®Google Scholar
• Koester, S., Glanz, J., Baron, A. (n.d.). Drug sharing among heroin networks: implications for HIV and hepatitis B and C prevention. Retrieved July 2, 2019, from https://www.ncbi.nlm.nih.gov/pubmed/15812611
   Google Scholar
• Koester, S., Glanz, J., & Barón, A. (2005a). Drug Sharing Among Heroin Networks: Implications for HIV and Hepatitis B and C Prevention. AIDS and Behavior, 9(1), 27–39. https://doi.org/10.1007/s10461-005-1679-y
   PubMed Web of Science ®Google Scholar
• Koester, S., Heimer, R., Barón, A. E., Glanz, J., Teng, W., Thorpe, L. E., Ouellet, L. J., Hershow, R., Bailey, S. L., Williams, I. T., Williamson, J., & Garfein, R. S. (2003). Re: “Risk of hepatitis C virus among young adult injection drug users who share injection equipment” (multiple letters). American Journal of Epidemiology, 157(4), 376–378. https://doi.org/10.1093/aje/kwf197
   PubMed Web of Science ®Google Scholar
• Kwiatkowski, C. F., Corsi, K. F., & Booth, R. E. (2002). The association between knowledge of hepatitis C virus status and risk behaviors in injection drug users. Addiction, 97(10), 1289–1294. https://doi.org/10.1046/j.1360-0443.2002.00208.x
   PubMed Web of Science ®Google Scholar
• Lauer, G. M., & Walker, B. D. (2001). Hepatitis C Virus Infection. The New England Journal of Medicine, 345(1), 41–52. https://doi.org/10.1056/NEJM200107053450107
   PubMed Web of Science ®Google Scholar
• Lekas, H.-M., Siegel, K., & Leider, J. (2011). Felt and Enacted Stigma Among HIV/HCV-Coinfected Adults: The Impact of Stigma Layering. Qualitative Health Research, 21(9), 1205–1219. https://doi.org/10.1177/1049732311405684
   PubMed Web of Science ®Google Scholar
• Liang, T. J., & Ward, J. W. (2018). Hepatitis C in injection-drug users – a hidden danger of the opioid epidemic. The New England Journal of Medicine, 378(13), 1169–1171. https://doi.org/10.1056/NEJMp1716871
   PubMed Web of Science ®Google Scholar
• Loewinger, G., Sharma, B., Karki, D. K., Khatiwoda, P., Kainee, S., & Poudel, K. C. (2016). Low knowledge and perceived Hepatitis C risk despite high risk behaviour among injection drug users in Kathmandu. International Journal of Drug Policy, 33, 75–82. https://doi.org/10.1016/j.drugpo.2016.05.005
   PubMed Web of Science ®Google Scholar
• Maher, L., Jalaludin, B., Chant, K. G., Jayasuriya, R., Sladden, T., Kaldor, J. M., & Sargent, P. L. (2006). Incidence and risk factors for hepatitis C seroconversion in injecting drug users in Australia. Addiction, 101(10), 1499–1508. https://doi.org/10.1111/j.1360-0443.2006.01543.x
   PubMed Web of Science ®Google Scholar
• Marks, P. W. (2013). Hematologic manifestations of liver disease. Seminars in Hematology, 50(3), 216–221. https://doi.org/10.1053/j.seminhematol.2013.06.003
   PubMed Web of Science ®Google Scholar
• Morissette, C., Cox, J., De, P., Tremblay, C., Roy, E., Allard, R., … Graves, L. (n.d.). Minimal uptake of sterile drug preparation equipment in a predominantly cocaine injecting population: Implications for HIV and hepatitis C prevention. https://www.sciencedirect.com/science/article/abs/pii/S0955395906001861
   Google Scholar
• Neale, J., & Stevenson, C. (2012). Routine exposure to blood within hostel environments might help to explain elevated levels of hepatitis C amongst homeless drug users: Insights from a qualitative study. International Journal of Drug Policy, 23(3), 248–250. https://doi.org/10.1016/j.drugpo.2012.01.002
   PubMed Web of Science ®Google Scholar
• Needle, R. H., Coyle, S., Cesari, H., Trotter, R., Clatts, M., Koester, S., Price, L., McLellan, E., Finlinson, A., Bluthenthal, R. N., Pierce, T., Johnson, J., Jones, T. S., & Williams, M. (1998). HIV Risk Behaviors Associated with the Injection Process: Multiperson Use of Drug Injection Equipment and Paraphernalia in Injection Drug User Networks. Substance Use & Misuse, 33(12), 2403–2423. https://doi.org/10.3109/10826089809059332
   PubMed Web of Science ®Google Scholar
• Needle, R., Fisher, D. G., Weatherby, N., Chitwood, D., Brown, B., Cesari, H., Booth, R., Williams, M. L., Watters, J., Andersen, M., & Braunstein, M. (1995). Reliability of self-reported HIV risk behaviors of drug users. Psychology of Addictive Behaviors, 9(4), 242–250. https://doi.org/10.1037/0893-164X.9.4.242
   Web of Science ®Google Scholar
• Nguyen, D. B., Gutowski, J., Ghiselli, M., Cheng, T., Bel Hamdounia, S., Suryaprasad, A., Xu, F., Moulton-Meissner, H., Hayden, T., Forbi, J. C., Xia, G.-L., Arduino, M. J., Patel, A., & Patel, P. R. (2016). A large outbreak of Hepatitis C virus infections in a hemodialysis clinic. Infection Control and Hospital Epidemiology, 37(2), 125–133. https://doi.org/10.1017/ice.2015.247
   PubMed Web of Science ®Google Scholar
• Ompad, D. C., Fuller, C. M., Vlahov, D., Thomas, D., & Strathdee, S. A. (2002). Lack of behavior change after disclosure of Hepatitis C Virus infection among young injection drug users in Baltimore, Maryland. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 35(7), 783–788. https://doi.org/10.1086/342063
   PubMed Web of Science ®Google Scholar
• Paintsil, E., Binka, M., Patel, A., Lindenbach, B. D., & Heimer, R. (2014). Hepatitis C Virus maintains infectivity for weeks after drying on inanimate surfaces at room temperature: Implications for risks of transmission. The Journal of Infectious Diseases, 209(8), 1205–1211. https://doi.org/10.1093/infdis/jit648
   PubMed Web of Science ®Google Scholar
• Palmateer, N., Hutchinson, S., McAllister, G., Munro, A., Cameron, S., Goldberg, D., & Taylor, A. (2014). Risk of transmission associated with sharing drug injecting paraphernalia: Analysis of recent hepatitis C virus (HCV) infection using cross-sectional survey data. Journal of Viral Hepatitis, 21(1), 25–32. https://doi.org/10.1111/jvh.12117
   PubMed Web of Science ®Google Scholar
• Platt, L., Minozzi, S., Reed, J., Vickerman, P., Hagan, H., French, C., … Hickman, M. (2017). Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs. Cochrane Database of Systematic Reviews, (9) https://doi.org/10.1002/14651858.CD012021.pub2
   Google Scholar
• Platt, L., Sweeney, S., Ward, Z., Guinness, L., Hickman, M., Hope, V., … Vickerman, P. (2017). Assessing the impact and cost-effectiveness of needle and syringe provision and opioid substitution therapy on hepatitis C transmission among people who inject drugs in the UK: An analysis of pooled data sets and economic modelling. http://europepmc.org/abstract/med/28968044 https://doi.org/10.3310/phr05050
   Google Scholar
• Pouget, E. R., Hagan, H., & Jarlais, D. C. D. (2012). Meta-analysis of hepatitis C seroconversion in relation to shared syringes and drug preparation equipment. Addiction (Abingdon, England)), 107(6), 1057–1065. https://doi.org/10.1111/j.1360-0443.2011.03765.x
   PubMed Web of Science ®Google Scholar
• Rhodes, T. (2002). The ‘risk environment’: A framework for understanding and reducing drug-related harm. International Journal of Drug Policy, 13(2), 85–94. https://doi.org/10.1016/S0955-3959(02)00007-5
   Google Scholar
• Rhodes, T., & Simic, M. (2005). Transition and the HIV risk environment. BMJ (Clinical Research ed.).), 331(7510), 220–223. https://doi.org/10.1136/bmj.331.7510.220
   PubMed Web of Science ®Google Scholar
• Rhodes, T., & Treloar, C. (2008). The social production of hepatitis C risk among injecting drug users: A qualitative synthesis. Addiction, 103(10), 1593–1603. https://doi.org/10.1111/j.1360-0443.2008.02306.x
   PubMed Web of Science ®Google Scholar
• Robinson, G. M., Reynolds, J. N., & Robinson, B. J. (1995). Hepatitis C prevalence and needle/syringe sharing behaviours in recent onset injecting drug users. The New Zealand Medical Journal, 108(996), 103–105.
   PubMed Web of Science ®Google Scholar
• Sattar, S. A., & Springthorpe, V. S. (1991). Survival and Disinfectant Inactivation of the Human Immunodeficiency Virus: A Critical Review. Reviews of Infectious Diseases, 13(3), 430–447. https://doi.org/10.1093/clinids/13.3.430
   Web of Science ®Google Scholar
• Spelman, T., Morris, M. D., Zang, G., Rice, T., Page, K., Maher, L., Lloyd, A., Grebely, J., Dore, G. J., Kim, A. Y., Shoukry, N. H., Hellard, M., & Bruneau, J. (2015). A longitudinal study of hepatitis C virus testing and infection status notification on behaviour change in people who inject drugs. J Epidemiol Community Health, 69(8), 745–752. https://doi.org/10.1136/jech-2014-205224
   PubMed Web of Science ®Google Scholar
• StataCorp. (2019). Stata Statistical Software: Release 16. StataCorp, LLC.
   Google Scholar
• Strike, C., Rotondi, M., Kolla, G., Roy, É., Rotondi, N. K., Rudzinski, K., Balian, R., Guimond, T., Penn, R., Silver, R. B., Millson, M., Sirois, K., Altenberg, J., & Hunt, N. (2014). Interrupting the social processes linked with initiation of injection drug use: Results from a pilot study. Drug and Alcohol Dependence, 137, 48–54. https://doi.org/10.1016/j.drugalcdep.2014.01.004
   PubMed Web of Science ®Google Scholar
• Sweeney, S., Ward, Z., Platt, L., Guinness, L., Hickman, M., Hope, V., Maher, L., Iversen, J., Hutchinson, S. J., Smith, J., Ayres, R., Hainey, I., & Vickerman, P. (2019). Evaluating the cost-effectiveness of existing needle and syringe programmes in preventing hepatitis C transmission in people who inject drugs. Addiction (Abingdon, England)), 114(3), 560–570. https://doi.org/10.1111/add.14519
   PubMed Web of Science ®Google Scholar
• Thompson, S. C., Boughton, C. R., & Dore, G. J. (2003). Blood-borne viruses and their survival in the environment: Is public concern about community needlestick exposures justified? Australian and New Zealand Journal of Public Health, 27(6), 602–607. https://doi.org/ 10.1111/j.1467-842X.2003.tb00606.x
   PubMed Web of Science ®Google Scholar
• Thorpe, L. E., Ouellet, L. J., Hershow, R., Bailey, S. L., Williams, I. T., Williamson, J., Monterroso, E. R., & Garfein, R. S. (2002). Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment. American Journal of Epidemiology, 155(7), 645–653. https://doi.org/10.1093/aje/155.7.645
   PubMed Web of Science ®Google Scholar
• Tsui, J. I., Vittinghoff, E., Hahn, J. A., Evans, J. L., Davidson, P. J., & Page, K. (2009). Risk behaviors after Hepatitis C Virus seroconversion in young injection drug users in San Francisco. Drug and Alcohol Dependence, 105(1-2), 160–163. https://doi.org/10.1016/j.drugalcdep.2009.05.022
   PubMed Web of Science ®Google Scholar
• Weatherby, N. L., Needle, R., Cesari, H., Booth, R., McCoy, C. B., Watters, J. K., Williams, M., & Chitwood, D. D. (1994). Validity of self-reported drug use among injection drug users and crack cocaine users recruited through street outreach. Evaluation and Program Planning, 17(4), 347–355. https://doi.org/10.1016/0149-7189(94)90035-3
   Web of Science ®Google Scholar
• Zibbell, J. E., Asher, A. K., Patel, R. C., Kupronis, B., Iqbal, K., Ward, J. W., & Holtzman, D. (2018). Increases in acute Hepatitis C virus infection related to a growing opioid epidemic and associated injection drug use, United States, 2004 to 2014. American Journal of Public Health, 108(2), 175–181. https://doi.org/10.2105/AJPH.2017.304132
   PubMed Web of Science ®Google Scholar